Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Global impact of the first year of COVID-19 vaccination: a mathematical modelling study
Oliver J. Watson, Gregory Barnsley, Jaspreet Toor, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 9, pp. 1293-1302
Open Access | Times Cited: 1374

Showing 1-25 of 1374 citing articles:

Covid-19 Vaccines — Immunity, Variants, Boosters
Dan H. Barouch
New England Journal of Medicine (2022) Vol. 387, Iss. 11, pp. 1011-1020
Open Access | Times Cited: 378
A survey of COVID-19 vaccine acceptance across 23 countries in 2022
Jeffrey V. Lazarus, Katarzyna Wyka, Trenton M. White, et al.
Nature Medicine (2023) Vol. 29, Iss. 2, pp. 366-375
Open Access | Times Cited: 275
Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination
Pascal Irrgang, Juliane Gerling, Katharina Kocher, et al.
Science Immunology (2022) Vol. 8, Iss. 79
Open Access | Times Cited: 173
A multinational Delphi consensus to end the COVID-19 public health threat
Jeffrey V. Lazarus, Diana Romero, Christopher J. Kopka, et al.
Nature (2022) Vol. 611, Iss. 7935, pp. 332-345
Open Access | Times Cited: 172
Vaccine Hesitancy: Contemporary Issues and Historical Background
Rina Fajri Nuwarda, Iqbal Ramzan, Lynn Weekes, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1595-1595
Open Access | Times Cited: 139
T Cell Responses to SARS-CoV-2
Alessandro Sette, John Sidney, Shane Crotty
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 343-373
Closed Access | Times Cited: 114
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years — IVY Network, 18 States, September 8–November 30, 2022
Diya Surie, Jennifer DeCuir, Yuwei Zhu, et al.
MMWR Morbidity and Mortality Weekly Report (2022) Vol. 71, Iss. 5152, pp. 1625-1630
Open Access | Times Cited: 106
Retrospectively modeling the effects of increased global vaccine sharing on the COVID-19 pandemic
Sam Moore, Edward M. Hill, Louise Dyson, et al.
Nature Medicine (2022) Vol. 28, Iss. 11, pp. 2416-2423
Open Access | Times Cited: 81
COVID-19, post-acute COVID-19 syndrome (PACS, “long COVID”) and post-COVID-19 vaccination syndrome (PCVS, “post-COVIDvac-syndrome”): Similarities and differences
Felix Scholkmann, Christian-Albrecht May
Pathology - Research and Practice (2023) Vol. 246, pp. 154497-154497
Open Access | Times Cited: 81
COVID-19 Mortality by Race and Ethnicity in US Metropolitan and Nonmetropolitan Areas, March 2020 to February 2022
Dielle J. Lundberg, Elizabeth Wrigley‐Field, Ahyoung Cho, et al.
JAMA Network Open (2023) Vol. 6, Iss. 5, pp. e2311098-e2311098
Open Access | Times Cited: 58
A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates
Payton A. Weidenbacher, Mrinmoy Sanyal, Natalia Friedland, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 57
Safety and effectiveness of vaccines against COVID-19 in children aged 5–11 years: a systematic review and meta-analysis
Vanessa Piechotta, Waldemar Siemens, Iris Thielemann, et al.
The Lancet Child & Adolescent Health (2023) Vol. 7, Iss. 6, pp. 379-391
Open Access | Times Cited: 51
‘Spikeopathy’: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA
Peter Parry, Astrid Lefringhausen, Conny Turni, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2287-2287
Open Access | Times Cited: 51
Outlook of pandemic preparedness in a post-COVID-19 world
B. Adam Williams, Charles H. Jones, Verna Welch, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 51
Knife’s edge: Balancing immunogenicity and reactogenicity in mRNA vaccines
Jisun Lee, Matthew C. Woodruff, Eui Ho Kim, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 7, pp. 1305-1313
Open Access | Times Cited: 50
SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiency
Yijia Li, Manish C. Choudhary, James Regan, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 731
Open Access | Times Cited: 48
mRNA vaccines: The future of prevention of viral infections?
Piotr Rzymski, Agnieszka Szuster−Ciesielska, Tomasz Dzieciątkowski, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Closed Access | Times Cited: 46
Vaccine access, equity and justice: COVID-19 vaccines and vaccination
Lois Privor-Dumm, Jean‐Louis Excler, Sarah Gilbert, et al.
BMJ Global Health (2023) Vol. 8, Iss. 6, pp. e011881-e011881
Open Access | Times Cited: 44
mRNA-1273 bivalent (original and Omicron) COVID-19 vaccine effectiveness against COVID-19 outcomes in the United States
Hung Fu Tseng, Bradley K. Ackerson, Lina S. Sy, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 44
Anti-PEG antibodies before and after a first dose of Comirnaty® (mRNA-LNP-based SARS-CoV-2 vaccine)
Yaelle Bavli, Bing‐Mae Chen, Guy Gross, et al.
Journal of Controlled Release (2023) Vol. 354, pp. 316-322
Open Access | Times Cited: 43
Duration of SARS-CoV-2 mRNA vaccine persistence and factors associated with cardiac involvement in recently vaccinated patients
Aram J. Krauson, Faye Victoria C. Casimero, Zakir Siddiquee, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 42
The impact of delayed access to COVID-19 vaccines in low- and lower-middle-income countries
Brenice Duroseau, Nodar Kipshidze, Rupali J. Limaye
Frontiers in Public Health (2023) Vol. 10
Open Access | Times Cited: 40
Safety and efficacy of COVID‐19 vaccines: A systematic review and meta‐analysis of controlled and randomized clinical trials
Jayesh Beladiya, Anup Kumar, Yogesh Vasava, et al.
Reviews in Medical Virology (2023) Vol. 34, Iss. 1
Closed Access | Times Cited: 39
Estimated number of lives directly saved by COVID-19 vaccination programmes in the WHO European Region from December, 2020, to March, 2023: a retrospective surveillance study
Margaux M. I. Meslé, Jeremy Brown, Piers Mook, et al.
The Lancet Respiratory Medicine (2024) Vol. 12, Iss. 9, pp. 714-727
Closed Access | Times Cited: 23
Does education influence COVID-19 vaccination? A global view
Dan Lupu, Ramona Țigănașu
Heliyon (2024) Vol. 10, Iss. 3, pp. e24709-e24709
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top